Equate Magnesium Citrate Saline Laxative Recalled Due to Microbial Contamination
Equate Magnesium Citrate saline laxative has been recalled for microbial contamination. The FDA Class I recall affects 18,324 bottles distributed in the US, Canada, and Panama.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall for microbial contamination in a non-sterile pharmaceutical product. Per FDA classification rules, Class I recalls carry a minimum severity of 4 (Severe). No deaths or serious injuries are reported in the source material.
Plain-English summary
Equate Magnesium Citrate, a saline laxative in 10 fl oz (296 mL) bottles with grape flavor, has been recalled by Walmart, Inc. on behalf of manufacturer Vi-Jon, LLC. The affected product is lot number 0525509 (expiration 3/6/2023, NDC 49035-592-38, UPC 681131287159).
The recall was issued due to microbial contamination in the non-sterile product.
The product was distributed nationwide in the United States, Canada, and Panama, with 18,324 bottles affected. Consumers should not use this product.
The recalled product
- Product
- equate Magnesium Citrate, SALINE LAXATIVE, (1.745g/fl oz) 10 FL OZ (296mL), Grape Flavor, Distributed By: Walmart, Inc. Bentonville, AR 72716; NDC 49035-592-38 UPC 6 81131 28715 9
- Manufacturer
- Vi-Jon, LLC
- Category
- Drug — Saline Laxative
- Hazard
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 0525509
- EXP 3/6/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27